IRIS - Res&Arch Institutional Research Information System - Research & Archive

GAETANI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.931
AS - Asia 1.598
EU - Europa 1.180
SA - Sud America 242
AF - Africa 42
OC - Oceania 7
Totale 5.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.881
SG - Singapore 746
IT - Italia 289
HK - Hong Kong 265
CN - Cina 260
IE - Irlanda 221
BR - Brasile 207
RU - Federazione Russa 129
DE - Germania 118
VN - Vietnam 98
KR - Corea 76
SE - Svezia 73
FI - Finlandia 70
GB - Regno Unito 52
IN - India 33
NL - Olanda 30
FR - Francia 28
CA - Canada 25
JP - Giappone 23
UA - Ucraina 23
PL - Polonia 21
RO - Romania 19
BD - Bangladesh 18
BE - Belgio 18
AT - Austria 17
CZ - Repubblica Ceca 17
ZA - Sudafrica 15
MX - Messico 12
TR - Turchia 12
AR - Argentina 11
UZ - Uzbekistan 11
ES - Italia 9
HR - Croazia 9
GR - Grecia 8
ID - Indonesia 8
IQ - Iraq 8
PK - Pakistan 7
CO - Colombia 6
EC - Ecuador 6
SA - Arabia Saudita 6
LT - Lituania 5
MA - Marocco 5
NZ - Nuova Zelanda 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
EG - Egitto 4
JM - Giamaica 4
PY - Paraguay 4
TN - Tunisia 4
DK - Danimarca 3
GE - Georgia 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
PT - Portogallo 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
GM - Gambi 2
GY - Guiana 2
IS - Islanda 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
HN - Honduras 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
PF - Polinesia Francese 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
RE - Reunion 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
ZM - Zambia 1
Totale 5.000
Salva come PNG Salva come JPEG
Città #
Singapore 510
Chandler 257
Hong Kong 256
Dublin 221
Ashburn 161
Perugia 141
Boardman 123
Santa Clara 83
Seoul 76
Los Angeles 73
Munich 69
San Mateo 68
Beijing 66
Altamura 59
Moscow 56
Des Moines 42
New York 42
Medford 40
Princeton 40
Andover 39
Lawrence 39
Ann Arbor 38
Wilmington 35
Piscataway 34
Helsinki 30
Ho Chi Minh City 30
Turku 26
Hanoi 24
Redmond 24
Denver 22
Boston 21
Chennai 19
Houston 19
São Paulo 19
Tokyo 19
Brooklyn 18
Redwood City 18
Amsterdam 17
The Dalles 17
Rome 15
Brussels 14
Nuremberg 14
Phoenix 14
Warsaw 14
Falls Church 13
Montreal 13
Stockholm 13
Vienna 13
Brno 12
Chicago 12
Dallas 12
Johannesburg 12
Orem 12
Manchester 11
London 10
Poplar 10
Timisoara 10
Frankfurt am Main 9
Seattle 9
Atlanta 8
Columbus 8
Hefei 8
Milan 8
Rio de Janeiro 8
San Francisco 8
Tashkent 8
Zagreb 8
Fairfield 7
Lappeenranta 7
Bucharest 6
Falkenstein 6
Norwalk 6
Saint Petersburg 6
Secaucus 6
Ankara 5
Auckland 5
Campinas 5
Dong Ket 5
Guangzhou 5
Haiphong 5
Woodbridge 5
Belo Horizonte 4
Mexico City 4
Ninh Bình 4
Porto Alegre 4
Shenzhen 4
Athens 3
Biên Hòa 3
Charlotte 3
Da Nang 3
Dhaka 3
Giza 3
Goiânia 3
Groningen 3
Izmir 3
Kingston 3
Lahore 3
Milwaukee 3
Mumbai 3
New Delhi 3
Totale 3.338
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 172
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 130
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 128
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 124
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 121
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 104
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 103
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 101
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 98
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 98
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 94
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 92
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 89
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 86
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 85
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 81
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 76
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 75
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 75
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 74
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 71
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease 70
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 68
Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms 68
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 67
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 66
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 66
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 66
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 65
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 64
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 63
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 63
Neurofilament light chain as a biomarker in neurological disorders 62
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 61
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 61
Biomarker-Based Prediction of Parkinson Disease: Time for a Shift in Neurologists' Attitude Toward Neurodegenerative Diseases 60
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 60
Infliximab monotherapy for neuro-Behçet's disease: a case report 59
Serum neurofilament light chain as a preclinical marker of neurodegeneration 59
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 59
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 59
Author Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use 58
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 58
Blood biomarkers may distinguish among dementia disorders 58
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 58
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 57
Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis? 56
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 55
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 55
A blood test for Alzheimer's disease: a step forward 55
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 54
Impact of post-contrast MRI in the definition of active multiple sclerosis 54
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 53
Intrathecal B cell activation and memory impairment in multiple sclerosis 52
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 52
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis. 52
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosis 51
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 51
Clinical correlates of state and trait anxiety in multiple sclerosis 51
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 50
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 50
CSF synaptic biomarkers and cognitive impairment in multiple sclerosis 49
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 49
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 49
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 49
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 47
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 44
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 43
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 43
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 43
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 42
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 42
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective 36
SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis 33
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 33
Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study 30
Hippocampal neuroplasticity and inflammation: Relevance for multiple sclerosis 30
Research advancement in fluid biomarkers for Parkinson's disease 30
Fluid biomarkers in multiple sclerosis: from current to future applications 25
Totale 5.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 17 7 20 11 5 6 7
2021/2022380 3 49 12 12 26 10 5 93 17 46 61 46
2022/2023858 45 184 15 68 62 104 4 38 302 1 26 9
2023/2024511 24 54 15 11 7 2 97 20 68 26 80 107
2024/20251.392 13 108 69 75 122 103 95 139 239 85 220 124
2025/20261.653 205 239 128 412 430 239 0 0 0 0 0 0
Totale 5.140